Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 44, 2018 - Issue 8
Submit an article Journal homepage
198
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells

Boshra AmiriBiochemistry Department, Faculty of Medicine, Lorestan University of Medical Science, Khorramabad, Iran; View further author information
,
Hasan AhmadvandBiochemistry Department, Faculty of Medicine, Lorestan University of Medical Science, Khorramabad, Iran; View further author information
,
Ali FarhadiSocial Medicine Department, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran; View further author information
,
Aazam NajmafsharClinical Biochemistry Department, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran; View further author information
,
Mohsen ChianiNanobiotechnology Department, Pasteur Institute of Iran, Tehran, IranCorrespondence[email protected]
View further author information
&
Dariush NorouzianNanobiotechnology Department, Pasteur Institute of Iran, Tehran, IranCorrespondence[email protected]
View further author information
Pages 1371-1376 | Received 03 Dec 2017, Accepted 08 Mar 2018, Published online: 11 Apr 2018

References

  • Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: new biological insights and recent therapeutic advances. CA Cancer J Clin. 2011;61:91–112.
  • Siegel R, Ward E, Brawley O, et al. Cancer statistics: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236.
  • Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
  • Moudi M, Go R, Yien CY, et al. Vinca alkaloids. Int J Prev Med. 2013;4:1231–1235.
  • Dandamudi S, Campbell RB. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials. 2007;28:4673–4683.
  • Nayak BS, Anderson M, Pinto Pereira LM. Evaluation of wound-healing potential of Catharanthus roseus leaf extract in rats. Fitoterapia. 2007;78:540–544.
  • Mahale NB, Thakkar PD, Mali RG, et al. Niosomes: novel sustained release nonionic stable vesicular systems-an overview. Adv Colloid Interface Sci. 2012;183:46–54.
  • Dwivedi A, Mazumder L, du Plessis JL, et al. In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells. Nanomedicine. 2015;11:2041–2050.
  • Gude RP, Jadhav MG, Rao SGA, et al. Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer Biother Radiopharm. 2002;17:183–192.
  • Mehrabi MR, Norouzian D, Shokrgozar MA, et al. Pegylated niosomal nanoparticles loaded with vincristine: characterization and in vitro evaluation. Trop J Pharm Res. 2017;16:975–980.
  • Abu Lila AS, Kizuki S, Doi Y, et al. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor suppression via a dual targeting approach in a murine solid tumor model. J Control Release. 2009;137:8–14.
  • Rajera R, Nagpal K, Singh SK, et al. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 2011;34:945–953.
  • Pua X, Liub J, Guoc Y, et al. Study progression in polymeric micelles for the targeting delivery of poorly soluble anticancer agents to tumor. Asian J Pharm Sci. 2012;7:1–17.
  • Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153:198–205.
  • Pasut G, Veronese FM. State of the art in PEGylation: the great versatility achieved after forty years of research. J Control Release. 2012;161:461–472.
  • Hong M, Zhu S, Jiang Y, et al. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release. 2009;133:96–102.
  • Lu B, Zhang JQ, Yang H. Nonphospholipid vesicles of carboplatin for lung targeting. Drug Delivery. 2003;10:87–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.